CEA

The Carcinoembryonic Antigen (CEA) assay is a cutting-edge diagnostic tool for detecting and monitoring cancer biomarkers, particularly in colorectal, breast, and lung cancers. This assay delivers fast, reliable, and highly sensitive results, empowering healthcare professionals to track disease progression, treatment efficacy, and recurrence in cancer patients.